Does armodafinil damage dopamine receptors?

Dopamine levels are impacted by armodafinil, the active component of Artvigil 150, which increases dopamine availability in the brain by preventing dopamine reuptake.  Current research does not demonstrate that armodafinil, when taken as directed, permanently damages dopamine receptors, despite the fact that this activity encourages wakefulness and alertness.  On the other hand, chronic or extreme abuse may interfere with the body's natural dopamine control.  In general, Artvigil 150 is regarded as safe and well-tolerated for the treatment of disorders such as shift work sleep disturbance and narcolepsy.  Avoid self-medicating or raising the dosage without a doctor's advice, and take Artvigil 150 under medical supervision to minimize hazards.